New Oligonucleotide 2′-O-Alkyl N3′→P5′ (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity
Nucleic Acid Therapeutics · 2023
DOI: 10.1089/nat.2023.0014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2023. Verfasst von Saúl Martínez-Montero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Pharmaceutical Companies of Johnson and Johnson, South San Francisco, California, USA. Hauptthemen laut MEDLINE: Oligonucleotides, Oligonucleotides, Antisense. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
We describe here the design, synthesis, physicochemical properties, and hepatitis B antiviral activity of new 2'-O-alkyl ribonucleotide N3'→P5' phosphoramidate (2'-O-alkyl-NPO) and (thio)-phosphoramidite (2'-O-alkyl-NPS) oligonucleotide analogs. Oligonucleotides with different 2'-O-alkyl modifications such as 2'-O-methyl, -O-ethyl, -O-allyl, and -O-methoxyethyl combined with 3'-amino sugar-phosphate backbone were synthesized and evaluated. These molecules form stable duplexes with complementary DNA and RNA strands. They show an increase in duplex melting temperatures of up to 2.5°C and 4°C per linkage, respectively, compared to unmodified DNA. The results agree with predominantly C3'-endo sugar pucker conformation. Moreover, 2'-O-alkyl phosphoramidites demonstrate higher hydrolytic stability at pH 5.5 than 2'-deoxy NPOs. In addition, the relative lipophilicity of the 2'-O-alkyl-NPO and NPS oligonucleotides is higher than that of their 3'-O- counterparts. The 2'-O-alkyl-NPS oligonucleotides were evaluated as antisense (ASO) compounds in vitro and in vivo using Hepatitis B virus as a model system. Subcutaneous delivery of GalNAc conjugated 2'-O-MOE-NPS gapmers demonstrated higher activity than the 3'-O-containing 2'-O-MOE counterpart. The properties of 2'-O-alkyl-NPS constructs make them attractive candidates as ASO suitable for further evaluation and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Janssen Pharmaceutical Companies of Johnson and Johnson, South San Francisco, California, USA.
ORCID-Profile: Soheil Pourshahian
Zitieren
APA
Martínez-Montero, S., Rajwanshi, V. K., Pandey, R. K., De Costa, N. T. S., Hong, J., Beigelman, L., Gryaznov, S. M., & Pourshahian, S. (2023). New Oligonucleotide 2′-O-Alkyl N3′→P5′ (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2023.0014
Vancouver
Martínez-Montero S, Rajwanshi VK, Pandey RK, De Costa NTS, Hong J, Beigelman L, et al. New Oligonucleotide 2′-O-Alkyl N3′→P5′ (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity. Nucleic Acid Therapeutics. 2023. doi:10.1089/nat.2023.0014
BibTeX
@article{MartnezMontero2023,
author = {Martínez-Montero, Saúl and Rajwanshi, Vivek K and Pandey, Rajendra K and De Costa, N Tilani S and Hong, Jin and Beigelman, Leonid and Gryaznov, Sergei M and Pourshahian, Soheil},
title = {New Oligonucleotide 2′-O-Alkyl N3′→P5′ (Thio)-Phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity},
journal = {Nucleic Acid Therapeutics},
year = {2023},
doi = {10.1089/nat.2023.0014}
}
EUVIMED